February 19-20, 2017 | Orlando, FL

Adherium, LTD (ASX: ADR) is a global leader in the design and development of evidence-based digital health solutions.

Our smart health platforms use connected devices, software, and data to improve health outcomes and the quality of life for patients with asthma, COPD and other chronic respiratory diseases.

As the pioneering company which founded Smartinhaler™ technologies, and having received FDA clearance to market in U.S. and CE marking in EU, Adherium has over 15 years of experience with significant clinical validation and a continually growing intellectual property estate.

Smartinhaler™ has been used in over 40 programs spanning 29 countries, resulting in a comprehensive body of peer-reviewed publications that demonstrate both accuracy and effectiveness of Adherium’s Smartinhaler™ solution.

Get Updates

Sign up to get the latest information on upcoming events.